Sol-Gel Technologies Ltd. (SLGL)
79.79
-1.93
(-2.36%)
USD |
NASDAQ |
Aug 26, 13:24
Sol-Gel Technologies Price to Book Value : 5.432 for Aug. 26, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 5.563 |
| August 24, 2026 | 5.268 |
| August 21, 2026 | 5.291 |
| August 20, 2026 | 5.343 |
| August 19, 2026 | 5.350 |
| August 18, 2026 | 5.400 |
| August 17, 2026 | 5.651 |
| August 14, 2026 | 5.765 |
| August 13, 2026 | 5.721 |
| August 12, 2026 | 4.867 |
| August 11, 2026 | 5.304 |
| August 10, 2026 | 5.768 |
| August 07, 2026 | 5.990 |
| August 06, 2026 | 5.916 |
| August 05, 2026 | 5.990 |
| August 04, 2026 | 5.752 |
| August 03, 2026 | 5.581 |
| July 31, 2026 | 5.599 |
| July 30, 2026 | 5.799 |
| July 29, 2026 | 5.619 |
| July 28, 2026 | 5.655 |
| July 27, 2026 | 5.434 |
| July 24, 2026 | 5.579 |
| July 23, 2026 | 5.483 |
| July 22, 2026 | 5.738 |
| Date | Value |
|---|---|
| July 21, 2026 | 6.109 |
| July 20, 2026 | 5.453 |
| July 17, 2026 | 5.664 |
| July 16, 2026 | 5.315 |
| July 15, 2026 | 5.256 |
| July 14, 2026 | 5.132 |
| July 13, 2026 | 5.031 |
| July 10, 2026 | 5.034 |
| July 09, 2026 | 5.198 |
| July 08, 2026 | 5.089 |
| July 07, 2026 | 5.340 |
| July 06, 2026 | 5.046 |
| July 02, 2026 | 5.038 |
| July 01, 2026 | 4.900 |
| June 30, 2026 | 5.047 |
| June 29, 2026 | 4.732 |
| June 26, 2026 | 4.674 |
| June 25, 2026 | 4.621 |
| June 24, 2026 | 4.668 |
| June 23, 2026 | 4.532 |
| June 22, 2026 | 4.693 |
| June 18, 2026 | 4.735 |
| June 17, 2026 | 4.474 |
| June 16, 2026 | 4.634 |
| June 15, 2026 | 4.694 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 5.630 |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 4.607 |
| Purple Biotech Ltd. | 0.2361 |
| PolyPid Ltd. | 19.49 |
Price to Book Value Related Metrics
| PS Ratio | 129.79 |
| PEG Ratio | -0.0345 |
| Price | 79.79 |
| Earnings Yield | -7.07% |
| Market Cap | 261.23M |
| PEGY Ratio | -0.0345 |